YAMAZAKI TOMOO 山崎智生

Researcher Number	90795684
Affiliation (based on the past Project Information) *help	2020 – 2021: 信州大学, 医学部附属病院, 助教(診療)
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related
Keywords	Principal Investigator 原発性胆汁性胆管炎 / 自己免疫性肝炎 / 消化器自己免疫疾患 / CD / UC / IBD / eQLT / eQTL / HLA / 炎症性腸疾患 / 自己免疫疾患

Analysis of gastrointestinal autoimmune diseases onset and the diversity of HLA antigen expression.Principal Investigator
- Principal Investigator
  
  YAMAZAKI TOMOO
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Shinshu University

All 2021 2020 2019

All Journal Article Presentation

[Journal Article] Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients2021
- Author(s)
  Umemura T, Joshita S, Saito H, Wakabayashi SI, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Ota M
- Journal Title
  
  Cancers (Basel)
  
  Volume: 29;13(13) Issue: 13 Pages: 3267-3267
- DOI
  10.3390/cancers13133267
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17019, KAKENHI-PROJECT-20K08282
[Journal Article] Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD2021
- Author(s)
  Kimura T, Tanaka N, Fujimori N, Yamazaki T, Katsuyama T, Iwashita Y, Pham J, Joshita S, Pydi SP, Umemura T.
- Journal Title
  
  Liver International
  
  Volume: 41(3) Issue: 3 Pages: 505-514
- DOI
  10.1111/liv.14776
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K17019
[Journal Article] Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients2021
- Author(s)
  Joshita S, Ota M, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Tanaka E, Umemura T.
- Journal Title
  
  Scientific Reports
  
  Volume: 11(1) Issue: 1
- DOI
  10.1038/s41598-021-01014-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17019, KAKENHI-PROJECT-20K08282
[Journal Article] Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals2021
- Author(s)
  Joshita S, Yamashita Y, Okamoto T, Usami Y, Sugiura A, Yamazaki T, Kakino A, Ota M, Sawamura T, Umemura T.
- Journal Title
  
  Hepatology Research
  
  Volume: 51(7) Issue: 7 Pages: 758-766
- DOI
  10.1111/hepr.13666
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17019
[Journal Article] Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese2020
- Author(s)
  Suzuki Hiroshi、Joshita Satoru、Hirayama Atsuhiro、Shinji Akihiro、Mukawa Kenji、Sako Minako、Yoshimura Naoki、Suga Tomoaki、Umemura Takeji、Ashihara Norihiro、Yamazaki Tomoo、Ota Masao
- Journal Title
  
  Scientific Reports
  
  Volume: 10 Issue: 1 Pages: 12424-12424
- DOI
  10.1038/s41598-020-69370-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08282, KAKENHI-PROJECT-20K17019
[Journal Article] Clinical utility of FibroScan as a non‐invasive diagnostic test for primary biliary cholangitis2019
- Author(s)
  Joshita Satoru、Yamashita Yuki、Sugiura Ayumi、Uehara Takeshi、Usami Yoko、Yamazaki Tomoo、Fujimori Naoyuki、Matsumoto Akihiro、Tanaka Eiji、Umemura Takeji
- Journal Title
  
  Journal of Gastroenterology and Hepatology
  
  Volume: - Issue: 7 Pages: 1208-1214
- DOI
  10.1111/jgh.14929
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09416, KAKENHI-PROJECT-20K08282, KAKENHI-PROJECT-20K17019
[Presentation] 急性肝不全におけるM2BPGiの臨床的意義と経時的変化の検討2021
- Author(s)
  山崎智生, 城下智, 梅村武司
- Organizer
  第107回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-20K17019
[Presentation] 薬物性肝障害生検例におけるM2BPGiを中心とした肝線維化マーカーの意義2021
- Author(s)
  山崎智生, 城下智, 梅村武司
- Organizer
  Japan Digestive Disease Week 2021
- Data Source
  KAKENHI-PROJECT-20K17019
[Presentation] 薬物性肝障害生検例におけるM2BPGiの意義と可溶性IL2受容体との関連2021
- Author(s)
  山崎智生, 城下智, 梅村武司
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K17019
[Presentation] M2BPGiおよびAutotaxinは薬物性肝障害における組織学的炎症を反映し得るか2020
- Author(s)
  山崎智生、城下智、梅村武司
- Organizer
  第56回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K17019
[Presentation] 予後・病型・成因ごとにみた急性肝不全におけるM2BPGiの臨床的意義の検討2020
- Author(s)
  山崎智生、城下智、梅村武司
- Organizer
  第43回日本肝臓学会東部会
- Data Source
  KAKENHI-PROJECT-20K17019
[Presentation] Liver injury mechanism and histological findings at onset of drug-induced liver injury using cytokeratin-18-related cell death markers, JDDW 2020, Kobe, Japan.2020
- Author(s)
  Tomoo Yamazaki, Satoru Joshita, Takeji Umemura
- Organizer
  Japan Digestive Disease Week 2020
- Data Source
  KAKENHI-PROJECT-20K17019
[Presentation] 原発性胆汁性胆管炎の非侵襲的病期診断法の臨床的有用性2020
- Author(s)
  城下智、山下裕騎、杉浦亜弓、山崎智生、梅村武司
- Organizer
  第117 回日本内科学会総会・講演会
- Data Source
  KAKENHI-PROJECT-20K17019

1. 梅村武司

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

YAMAZAKI TOMOO 山崎 智生

Research Projects

Research Products

Co-Researchers

Analysis of gastrointestinal autoimmune diseases onset and the diversity of HLA antigen expression.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical utility of FibroScan as a non‐invasive diagnostic test for primary biliary cholangitis2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] 急性肝不全におけるM2BPGiの臨床的意義と経時的変化の検討2021

Author(s)

Organizer

Data Source

[Presentation] 薬物性肝障害生検例におけるM2BPGiを中心とした肝線維化マーカーの意義2021

Author(s)

Organizer

Data Source

[Presentation] 薬物性肝障害生検例におけるM2BPGiの意義と可溶性IL2受容体との関連2021

Author(s)

Organizer

Data Source

[Presentation] M2BPGiおよびAutotaxinは薬物性肝障害における組織学的炎症を反映し得るか2020

Author(s)

Organizer

Data Source

[Presentation] 予後・病型・成因ごとにみた急性肝不全におけるM2BPGiの臨床的意義の検討2020

Author(s)

Organizer

Data Source

[Presentation] Liver injury mechanism and histological findings at onset of drug-induced liver injury using cytokeratin-18-related cell death markers, JDDW 2020, Kobe, Japan.2020

Author(s)

Organizer

Data Source

[Presentation] 原発性胆汁性胆管炎の非侵襲的病期診断法の臨床的有用性2020

Author(s)

Organizer

Data Source

YAMAZAKI TOMOO 山崎智生